APA (7th ed.) Citation

M, E., N, E., C, K., L, S., M, P., B, G., . . . R, B. E. (2026). Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathy. Scientific reports. https://doi.org/10.1038/s41598-026-51879-z

Chicago Style (17th ed.) Citation

M, Eslami, et al. "Fibroblast Growth Factor 23 Is Associated with Cardiac Disease Severity in Transthyretin Amyloid Cardiomyopathy." Scientific Reports 2026. https://doi.org/10.1038/s41598-026-51879-z.

MLA (9th ed.) Citation

M, Eslami, et al. "Fibroblast Growth Factor 23 Is Associated with Cardiac Disease Severity in Transthyretin Amyloid Cardiomyopathy." Scientific Reports, 2026, https://doi.org/10.1038/s41598-026-51879-z.